Lorenza Rimassa

71PUBLICATIONS

317CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer diagnosisCancer cell biologyPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (71)

Sort by Publication Date:

|Jun 10, 2026

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

|Jun 01, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.

|Dec 10, 2025

Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Oct 08, 2025

Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review.

Teresa Macarulla, Cindy Neuzillet, Gerald W Prager

|Sep 06, 2025

Letter Re: Reflections on the MAGIC-D Prognostic Model in Advanced Biliary Tract Cancer.

Mara Persano, Margherita Rimini, Lorenzo Fornaro

|Aug 14, 2025

Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis.

Michele Ghidini, Fausto Petrelli, Matteo Paccagnella

Pageof 12

Frequent Collaborators

18 joint publications

Nicola Personeni

15 joint publications

Antonio D'Alessio

11 joint publications

Antonella Cammarota

Tiziana Pressiani

Valentina Zanuso

Silvia Bozzarelli

Ana Lleo

Matthias Pinter

Yi-Hsiang Huang

David James Pinato

Frequent Collaborators

18 joint publications

Nicola Personeni

15 joint publications

Antonio D'Alessio

11 joint publications

Antonella Cammarota

9 joint publications

Tiziana Pressiani